Benzinga | Nov 9, 2021 11:11AM EST

Aprea Therapeutics Q3 EPS $(0.45) Up From $(0.58) YoY

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.45) per share. This is a 22.41 percent increase over losses of $(0.58) per share from the same period last year.